Skip to content

Study · Not a test of the peptide alone · 2007

1 result

Localization of insulin-like growth factor (IGFBP)-3 in cultured porcine embryonic myogenic cells before and after TGF-beta1 treatment.

Xi G, Hathaway MR, White ME, Dayton WR

Domestic animal endocrinology25 Sept 2006Cited by 11 (Europe PMC)

PMID17049199 (opens in a new tab)DOI10.1016/j.domaniend.2006.08.006 (opens in a new tab)PepBankPUB-17049199
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, IGF-1 LR3 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking IGF-1 LR3.

  1. 01LabNot a test of IGF-1 LR3 aloneIn vitro (cells)Mechanism

    In cultured porcine embryonic myogenic cells, IGFBP-3 had no effect on Long-R3-IGF-I-stimulated differentiation, while it suppressed IGF-I-stimulated differentiation.

    In plain wordsIn pig muscle cells grown in the lab, IGFBP-3 did not change differentiation driven by Long-R3-IGF-I.

    Peptide
    IGF-1 LR3
    Outcome
    No significant changeIGFBP-3 effect on Long-R3-IGF-I-stimulated differentiation
    Study

    pign: not reported in source

    cultured porcine embryonic myogenic cells
    Comparator
    IGF-I-stimulated differentiation
    Outcome group
    Receptor activity and mechanism · Musculoskeletal

    Source sentences

    Summary
    IGFBP-3 suppresses IGF-I-stimulated differentiation of PEMC but has no affect on Long-R3-IGF-I-stimulated differentiation of PEMC.
    1 context sentence
    Summary · context
    IGFBP-3 is produced by porcine embryonic myogenic cell (PEMC) cultures.

    In this study, IGF-1 LR3 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking IGF-1 LR3.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.